retatrutide approval status 2025 HAS NOT BEEN APPROVED YET & CURRENTLY IN PHASE III CLINICAL TRIALS⛔️ Retatrutide is not currently FDA-approved, as it is in Phase III clinical trials with anticipated completion in 2025–2026 and How Long Does Retatrutide Take

Image Credit: Love Employee / Shutterstock In a recent study published in the journal BMJ Medicine , researchers conducted a target trial emulation to assess associations between different scenarios of glucagon-like peptide-1 receptor agonist (GLP-1RA) treatment and the risk of major adverse cardiovascular events (MACE)

Back Nair, P (2024) 'QnAs with Svetlana Mojsov, Joel Habener, and Lotte Bjerre Knudsen: Winners of the 2024 Lasker~DeBakey Clinical Medical Research Award', Proceedings of the National Academy of Sciences , 121/39, e2416868121

These studies often involve both human trials and laboratory tests

Anti-nausea medications can be used if needed

The Medicare Advantage and Prescription Drug Plan Annual Election Period starts Oct

We create a personalized plan for each individual based on lab values, symptoms, and overall health history